SUBSCRIBE: Print / Digital / eNewsletter
With issues surrounding COVID-19, the coronavirus, grabbing headlines across the country and around the globe, ophthalmologists must understand the risks to be informed and positioned to provide quality care for their patients. Click here to follow Ophthalmology Times'® ongoing coverage on the impact of the novel virus not only in ophthalmology, but the healthcare field as a whole.
This article was reviewed by Andrew G. Lee, MD
When diagnosing posterior uveitis, three considerations are important when using optical coherence tomography (OCT), according to Kathryn Pepple, MD, PhD.
For graduates and residents, the spring of 2020 promised to be a special time as they took the next step in their careers in ophthalmology in the “Year of the Eye.” It has turned out to be memorable for different reasons.
Ophthalmology Times' David Hutton speaks with John A.
Special to Ophthalmology Times®
Jeanne Hecht, Ora chief executive officer, discusses the significance of clinical research as a care option with Sheryl Stevenson, Ophthalmology Times
Special to Ophthalmology Times
Ophthalmology Times' Sheryl Stevenson speaks with Kala Pharmaceuticals' James Yanek, director of professional relations, and Desiree Owen, OD, associate director of Medical Science Liaisons at
This article was reviewed by Elizabeth Yeu, MD
Ophthalmology Times' David Hutton speaks with Cynthia Matossian, MD, FACS, on her presentation "Real-world efficacy of DEXYCU (dexamethasone intraocular suspension) 9% retrospectiv
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
